MD Anderson research shows modern chemotherapies are tied to a small but significant increased risk of secondary MDS and AML in older breast cancer patients. These findings may help oncologists understand their patients’ risks and better inform discussions with them.
Leukemia in adults: Common types, symptoms, and treatment
Non-Hodgkin's Lymphoma Patients Are at Increased Risk of Second Cancers - CancerConnect
Leukemia: Definition, Types & Risk Factors
Trends in FDA-Approved Cancer Therapies
Childhood Acute Lymphoblastic Leukemia Treatment - NCI
Understanding Leukemia Relapse
Blood Cancer Awareness Month: Know the Risk Factors of Blood Cancer - CARTI
Investigating the Side Effects of Cancer Immunotherapy - NCI
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Children with ALL Can Skip Brain Radiation - NCI
New U.S. cancer drug prices rise 53% in five years -report
